Stereotactic arrhythmia radiotherapy (STAR) is a promising noninvasive treatment for cardiac arrhythmias. Traditional motion expansion PTVs are well-suited to oncology but little is known about their use for STAR. We propose and evaluate a novel myocardial ta...
Author profile
Matthew J. Nyflot, PhD
Department of Radiation Oncology, University of Washington
Myocardial Target Volume: Defining a Physiologically Relevant Target Structure for Stereotactic Arrhythmia Radiotherapy
Poster Program · Therapy Physics
Voxel-Wise Characterization of Post-Radiotherapy Liver Function Changes Using Longitudinal Sulfur Colloid SPECT/CT
Patients receiving radiotherapy (RT) for liver cancer have limited liver function reserves, which increases risk of radiation-induced liver injury, but tools to evaluate functional response post-RT are lacking. We modeled liver function changes on 99mTc sulfu...
Proffered Program · Therapy Physics
Cardiorespiratory Motion Management for STAR with Ultra-High Dose Rate Proton Therapy
Stereotactic arrhythmia radioablation (STAR), a non-invasive treatment option for refractory ventricular tachycardia (VT), faces challenges from combined respiratory and cardiac motion, necessitating large target margins or motion mitigation. Respiratory gati...
Proffered Program · Therapy Physics